-
181
-
182
-
183
Engineering Soil Quality and Water Productivity Through Optimal Phosphogypsum Application Rates
Published 2024-12-01Get full text
Article -
184
-
185
Enhanced Forecasting and Assessment of Urban Air Quality by an Automated Machine Learning System: The AI‐Air
Published 2025-01-01“…Abstract An automated air quality forecasting system (AI‐Air) was developed to optimize and improve air quality forecasting for different typical cities, combined with the China Meteorological Administration Unified Atmospheric Chemistry Environmental Model (CUACE), and used in a typical inland city of Zhengzhou and a coastal city of Haikou in China. The performance evaluation results show that for the PM2.5 forecasts, the correlation coefficient (R) is increased by 0.07–0.13, and the mean error (ME) and root mean square error (RMSE) is decreased by 3.2–3.5 and 3.8–4.7 μg/m³. …”
Get full text
Article -
186
-
187
-
188
-
189
-
190
-
191
-
192
Clinical Features and Prognosis of Double-Positive Anti-MDA5 and Anti-CCP Antibodies in Dermatomyositis: A Retrospective Study
Published 2025-02-01“…Xiayu Xu,1 Longyang Zhu,2 Sizhao Li,3 Guochun Wang,3 Yongpeng Ge3 1Department of Rheumatology and Immunology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan Province, People’s Republic of China; 2Peking University, China-Japan Friendship School of Clinical Medicine, Beijing, People’s Republic of China; 3Department of Rheumatology, The Key Laboratory of Myositis, China-Japan Friendship Hospital, Beijing, People’s Republic of ChinaCorrespondence: Yongpeng Ge, Department of Rheumatology, The Key Laboratory of Myositis, China-Japan Friendship Hospital, Beijing, 100029, People’s Republic of China, Email gyp2016@163.comObjective: To investigate the clinical features and prognosis of anti-melanoma differentiation-related gene 5 (MDA5) antibody and anti-cyclic citrullinated peptide (CCP) antibody double-positive dermatomyositis (DM) (MDA5+/CCP+ DM).Methods: A retrospective analysis of 264 consecutive cases of MDA5+ DM hospitalized from March 2018 to March 2022, and patients with anti-CCP antibodies were screened out. …”
Get full text
Article -
193
-
194
-
195
-
196
-
197
-
198
Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China
Published 2018-01-01Get full text
Article -
199
-
200